Post-stroke hyperglycaemia – Treatment with Exenatide in Acute Ischaemic Stroke (TEXAIS) trial

中风后血糖水平升高（高血糖症）是常见的。它降低了中风治疗的疗效，并导致更差的结果。胰岛素不能作为治疗药物，因为它会导致频繁的低血糖，并且不能改善临床结局。艾塞那肽是一种常见的糖尿病药物，使用简单，可降低血糖而不会导致低血糖。它将在艾塞那肽治疗急性缺血性卒中（TEXAIS）试验中进行测试。

Raised blood glucose levels (hyperglycaemia) after a stroke is common. It reduces the efficacy of stroke treatments and results in worse outcomes. Insulin is not useful as a treatment for this as it causes frequent hypoglycaemia and does not improve clinical outcomes. Exenatide is a common diabetes drug that is simple to use and lowers blood glucose without hypoglycaemia. It will be tested in the Treatment with Exenatide in Acute Ischaemic Stroke (TEXAIS) trial.